1. Andén NE, Ålander T, Grabowska-Andén M, Liljenberg B, Lindgren S, Thornstrom U (1984) The pharmacology of pre- and postsynaptic dopamine receptors; differential effects of dopamine receptor agonists and antagonists. In: Usdin E, Carlsson A, Dahlstrom A, Engel J A (eds) Catecholamines, vol. B. Liss, New York, p 19
2. Arnt J, Hyttel J (1984) Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxydopamine lesions and by chronic reserpine treatment in rats. Neural Transm 60
3. Arnt J, Christensen AV, Hyttel J, Larsen JJ, Svendsen O (1982) Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity. Eur J Pharmacol 86: 185–198
4. Arnt J, Bógesó KP, Christensen AV, Hyttel J, Larsen JJ, Svendsen O (1983) Dopamine receptor agonistic effects of 3-PPP enantiomers. Psychopharmacology 81: 199–207
5. Carlsson A (1983) Are “on-off” effects during chronic L-dopa treatment due to faulty feedback control of the nigrostriatal dopamine pathway? J Neural Transm [Suppl] 19: 153–161